Atlas Trials

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Clinical trial NCT04244708 · UNKNOWN

Trial details

NCT number
NCT04244708
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Pituitary Adenomas
Start date
2020-02-10
Primary completion
2022-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.